# Comparison of Short Versus 12 Months Prasugrel Plus Aspirin in Patients With Acute Coronary Syndromes Treated With Percutaneous Coronary Intervention and Everolimus-eluting Stents

Study · id `cardio:ct-nct06718179` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06718179](<https://clinicaltrials.gov/study/NCT06718179>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT06718179

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 130 participants.

## Technical summary

Registry record NCT06718179. Randomized; single masking; primary purpose treatment. Start 2024-11-16 (actual); primary completion 2025-05-25 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 130 participants (enrolled count; ClinicalTrials.gov record NCT06718179, source copy `cardio:ctgov-nct06718179-2026-10-22`, retrieved 2026-10-31)
- Started: 2024-11-16 (actual) (ClinicalTrials.gov record NCT06718179, source copy `cardio:ctgov-nct06718179-2026-10-22`, retrieved 2026-10-31)
- Primary completion: 2025-05-25 (actual) (ClinicalTrials.gov record NCT06718179, source copy `cardio:ctgov-nct06718179-2026-10-22`, retrieved 2026-10-31)
- Completion: 2025-05-30 (actual) (ClinicalTrials.gov record NCT06718179, source copy `cardio:ctgov-nct06718179-2026-10-22`, retrieved 2026-10-31)
- Countries: Denmark (ClinicalTrials.gov record NCT06718179, source copy `cardio:ctgov-nct06718179-2026-10-22`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "TERMINATED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06718179-2026-10-22`, retrieved 2026-10-31)

## The registry's words

- Brief title: Comparison of Short Versus 12 Months Prasugrel Plus Aspirin in Patients With Acute Coronary Syndromes Treated With Percutaneous Coronary Intervention and Everolimus-eluting Stents
- Acronym: SORT OUT DAPT
- Condition: Acute Coronary Syndrome
- Intervention (Drug): Short duration of aspirin and prasugrel
- Intervention (Drug): Conventional duration of aspirin and prasugrel
- Lead sponsor: Odense University Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Acute coronary syndrome (`cardio:acute-coronary-syndrome`)
- Registry lists this organization as the lead sponsor: Odense University Hospital (`cardio:org-odense-university-hospital`)

## Provenance

Content hash: 01af1d4ff937adfb7efc98eee91a49e9ad3bc9778b47c8466a3273625242864d
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
